Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation (AVRO)
This study is currently recruiting participants.
Study NCT00668759   Information provided by Cardiome Pharma
First Received: April 25, 2008   Last Updated: October 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Atrial Fibrillation
More general conditions related to this trial
Arrhythmias, Cardiac
Cardiovascular Diseases
Heart Diseases
Pathologic Processes
Interventions listed in this trial
Vernakalant Injection
Amiodarone Injection:
Additional drug interventions recognized in this trial
Amiodarone
More general drug interventions related to this trial
Anti-Arrhythmia Agents
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Cardiome Pharma


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services